Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
Naci, Huseyin, Davis, Courtney, SavoviÄ, Jelena, Higgins, Julian P T, Sterne, Jonathan A C, Gyawali, Bishal, Romo-Sandoval, Xochitl, Handley, Nicola, Booth, Christopher MJournal:
BMJ
DOI:
10.1136/bmj.l5221
Date:
September, 2019
Fichier:
PDF, 660 KB
2019
File converter
Plus de résultats de recherche
More benefits 
